GLPBio

Prostaglandins

Products Related to Prostaglandins(462)

  • GC18235 structure
    GC182351-O-Hexadecyl-sn-glycerol
    CAS: 506-03-6
    Purity: >98.00%

    1-O-Hexadecyl-sn-glycerol is a bioactive alkyl glyceryl ether.

  • GC18250 structure
    GC18250Prostaglandin B1
    CAS: 13345-51-2
    Purity: >98.00%

    Prostaglandin B1 (PGB1) is a non-enzymatic dehydration product of PGE1 resulting from treatment with strong base.

  • GC18271 structure
    GC18271Polmacoxib
    CAS: 301692-76-2
    Purity: >98%

    Polmacoxib (CG100649) ist das erste oral wirksame nichtsteroidale Antirheumatikum (NSAID) seiner Klasse, das ein dualer Inhibitor von COX-2 (IC50 etwa 0,1 μg/ml) und Carboanhydrase ist. Polmacoxib hemmt kolorektale Adenome und Tumorwachstum in Mausmodellen.

  • GC18310 structure
    GC18310Prostaglandin A1
    CAS: 14152-28-4
    Purity: >98.00%

    Prostaglandin A1 (PGA1) was first isolated as a dehydration product of the PGE1 compounds found in human semen.

  • GC18320 structure
    GC1832015-keto Prostaglandin E1
    CAS: 22973-19-9
    Purity: >98.00%

    15-keto PGE1 is the inactive metabolite of PGE1 produced by 15-hydroxy PGDH.

  • GC18353 structure
    GC18353Prostaglandin A2
    CAS: 13345-50-1
    Purity: >98.00%

    A naturally occurring prostaglandin with antiviral/antitumor activity

  • GC18370 structure
    GC18370Prostaglandin F2α methyl ester
    CAS: 33854-16-9
    Purity: >98%

    Prostaglandin F2α methyl ester (PGF2α methyl ester) is an analog of PGF2α in which the C-1 carboxyl group has been esterified as the methyl ester.

  • GC18372 structure
    GC1837215(S)-15-methyl Prostaglandin F2α methyl ester
    CAS: 35700-21-1
    Purity: >98%

    15(S)-15-methyl PGF2α methyl ester is a derivative of 15(S)-15-methyl PGF2α with increased membrane permeability.

  • GC18381 structure
    GC18381Prostaglandin H2
    CAS: 42935-17-1
    Purity: >95.00%

    Prostaglandin H2 (PGH2) was first isolated from incubations of arachidonic acid with ovine seminal vesicle microsomes, and was described as a potent vasoconstrictor.

  • GC18390 structure
    GC18390Prostaglandin G2
    CAS: 51982-36-6
    Purity: >95.00%

    Prostaglandin G2 (PGG2) is the first intermediate in the COX pathway which is stable enough to be isolated and characterized.

  • GC18393 structure
    GC183936-keto Prostaglandin F1α
    CAS: 58962-34-8
    Purity: >98.00%

    6-keto prostaglandin F1α (6-keto PGF1α) is the inactive, non-enzymatic hydrolysis product of PGI2.

  • GC18411 structure
    GC18411Prostaglandin B2
    CAS: 13367-85-6
    Purity: >98.00%

    Prostaglandin B2 (PGB2) is a non-enzymatic dehydration product resulting from the treatment of PGE2 or PGA2 with strong base.

  • GC18527 structure
    GC185274'-hydroxy Flurbiprofen
    CAS: 52807-12-2
    Purity: >98%

    A major active metabolite of flurbiprofen

  • GC18573 structure
    GC18573Tafluprost ethyl amide
    CAS: 1185851-52-8
    Purity: >98%

    Tafluprost-Ethylamid ist ein Prostaglandin-Derivat.

  • GC18582 structure
    GC185825'-hydroxy Meloxicam
    CAS: 130262-92-9
    Purity: >98%

    A metabolite of meloxicam

  • GC18617 structure
    GC1861711β-Prostaglandin E1
    CAS: 24570-01-2
    Purity: >98%

    11β-Prostaglandin E1 (11β-PGE1) is an epimerized form of PGE1 at the C-11 position.

  • GC18634 structure
    GC1863411-deoxy Prostaglandin E1
    CAS: 37786-00-8
    Purity: >98.00%

    11-deoxy Prostaglandin E1 (11-deoxy PGE1) is a synthetic analog of PGE1.

  • GC18637 structure
    GC1863711β-Prostaglandin F2α
    CAS: 38432-87-0
    Purity: >98.00%

    11β-Prostaglandin F2α (11β-PGF2α) is the primary plasma metabolite of PGD2 in vivo.

  • GC18653 structure
    GC18653Prostaglandin J2
    CAS: 60203-57-8
    Purity: >95.00%

    Prostaglandin J2 (PGJ2) is formed from PGD2 by the elimination of the C-9 hydroxyl group, a process which is accelerated by the presence of albumin.

  • GC18688 structure
    GC18688CAY10589
    CAS: 1077626-52-8
    Purity: >98%

    Microsomal Prostaglandin E2 Synthase-1 (mPGES-1), with cyclooxygenase-2 (COX-2), synthesizes PGE2, which is directly involved in signaling during inflammation, fever and pain.

  • GC18710 structure
    GC18710CAY10700
    CAS: 1381846-21-4
    Purity: >98%

    Prostaglandin E2 is the major PG synthesized at sites of inflammation and plays an important role in different inflammatory diseases.

  • GC18738 structure
    GC18738Prostaglandin E1 Ethanolamide
    CAS: 210976-81-1
    Purity: >98%

    Prostaglandin E1 ethanolamide (PGE1-EA) is the ethanolamine-amide analog of PGE1.

  • GC18739 structure
    GC1873917-trans Prostaglandin E3
    CAS: 210979-33-2
    Purity: >98%

    17-trans PGE3 is an isomer of PGE3 which could theoretically result from the COX metabolism of dietary trans-fatty acids.

  • GC18740 structure
    GC18740Prostaglandin E1 Alcohol
    CAS: 21562-57-2
    Purity: >98.00%

    Prostaglandin E1 (PGE1) alcohol is a non-irritant bronchodilator, with relaxant activity on the human bronchial muscle in vitro, comparable to PGE1 at concentrations of 0.01 to 10.0 ug/ml.